Literature DB >> 31214855

Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Kurt A Jellinger1.   

Abstract

Extrapyramidal movement disorders include hypokinetic rigid and hyperkinetic or mixed forms, most of them originating from dysfunction of the basal ganglia (BG) and their information circuits. The functional anatomy of the BG, the cortico-BG-thalamocortical, and BG-cerebellar circuit connections are briefly reviewed. Pathophysiologic classification of extrapyramidal movement disorder mechanisms distinguish (1) parkinsonian syndromes, (2) chorea and related syndromes, (3) dystonias, (4) myoclonic syndromes, (5) ballism, (6) tics, and (7) tremor syndromes. Recent genetic and molecular-biologic classifications distinguish (1) synucleinopathies (Parkinson's disease, dementia with Lewy bodies, Parkinson's disease-dementia, and multiple system atrophy); (2) tauopathies (progressive supranuclear palsy, corticobasal degeneration, FTLD-17; Guamian Parkinson-dementia; Pick's disease, and others); (3) polyglutamine disorders (Huntington's disease and related disorders); (4) pantothenate kinase-associated neurodegeneration; (5) Wilson's disease; and (6) other hereditary neurodegenerations without hitherto detected genetic or specific markers. The diversity of phenotypes is related to the deposition of pathologic proteins in distinct cell populations, causing neurodegeneration due to genetic and environmental factors, but there is frequent overlap between various disorders. Their etiopathogenesis is still poorly understood, but is suggested to result from an interaction between genetic and environmental factors. Multiple etiologies and noxious factors (protein mishandling, mitochondrial dysfunction, oxidative stress, excitotoxicity, energy failure, and chronic neuroinflammation) are more likely than a single factor. Current clinical consensus criteria have increased the diagnostic accuracy of most neurodegenerative movement disorders, but for their definite diagnosis, histopathological confirmation is required. We present a timely overview of the neuropathology and pathogenesis of the major extrapyramidal movement disorders in two parts, the first one dedicated to hypokinetic-rigid forms and the second to hyperkinetic disorders.

Entities:  

Keywords:  Genetics; Lewy body pathology; Movement disorders; Neuropathology; Parkinsonism; Pathophysiology; Polyglutamine repeat disorder; Proteinopathies; Tauopathies

Year:  2019        PMID: 31214855     DOI: 10.1007/s00702-019-02028-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  874 in total

1.  Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service.

Authors:  J Kamin; S Manwani; D Hughes
Journal:  Psychiatr Serv       Date:  2000-03       Impact factor: 3.084

2.  A Drosophila model of Parkinson's disease.

Authors:  M B Feany; W W Bender
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

3.  The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease.

Authors:  C Russ; S Lovestone; M Baker; S M Pickering-Brown; P M Andersen; R Furlong; D Mann; J F Powell
Journal:  Neurosci Lett       Date:  2001-02-16       Impact factor: 3.046

4.  Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

Authors:  G Münch; H J Lüth; A Wong; T Arendt; E Hirsch; R Ravid; P Riederer
Journal:  J Chem Neuroanat       Date:  2000-12       Impact factor: 3.052

5.  Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells.

Authors:  Fumiaki Mori; Chikanori Inenaga; Makoto Yoshimoto; Hajime Umezu; Ryuichi Tanaka; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Acta Neuropathol       Date:  2001-10-18       Impact factor: 17.088

6.  The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease.

Authors:  B C Campbell; C A McLean; J G Culvenor; W P Gai; P C Blumbergs; P Jäkälä; K Beyreuther; C L Masters; Q X Li
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

7.  Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.

Authors:  H Houlden; M Baker; H R Morris; N MacDonald; S Pickering-Brown; J Adamson; A J Lees; M N Rossor; N P Quinn; A Kertesz; M N Khan; J Hardy; P L Lantos; P St George-Hyslop; D G Munoz; D Mann; A E Lang; C Bergeron; E H Bigio; I Litvan; K P Bhatia; D Dickson; N W Wood; M Hutton
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

8.  Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E.

Authors:  Takashi Togo; Natalie Cookson; Dennis W Dickson
Journal:  Brain Pathol       Date:  2002-01       Impact factor: 6.508

9.  Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure.

Authors:  J W Langston; L S Forno; J Tetrud; A G Reeves; J A Kaplan; D Karluk
Journal:  Ann Neurol       Date:  1999-10       Impact factor: 10.422

10.  Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study.

Authors:  José Berciano; Francesc Valldeoriola; Isidre Ferrer; Jordi Rumià; Julio Pascual; Concepción Marín; María J Rey; Eduardo Tolosa
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

View more
  5 in total

Review 1.  Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.

Authors:  Jelena Osmanovic Barilar; Ana Knezovic; Ana Babic Perhoc; Jan Homolak; Peter Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2020-02-06       Impact factor: 3.575

2.  Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion.

Authors:  Qilin Tang; Pan Gao; Thomas Arzberger; Matthias Höllerhage; Jochen Herms; Günter Höglinger; Thomas Koeglsperger
Journal:  Cell Death Dis       Date:  2021-09-17       Impact factor: 8.469

Review 3.  Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.

Authors:  P Riederer; C Monoranu; S Strobel; T Iordache; J Sian-Hülsmann
Journal:  J Neural Transm (Vienna)       Date:  2021-10-12       Impact factor: 3.575

Review 4.  The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.

Authors:  Jeswinder Sian-Hulsmann; Peter Riederer
Journal:  Cells       Date:  2021-03-09       Impact factor: 6.600

Review 5.  Neuropathology of multiple system atrophy: Kurt Jellinger`s legacy.

Authors:  Nicole Campese; Alessandra Fanciulli; Nadia Stefanova; Johannes Haybaeck; Stefan Kiechl; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2021-07-28       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.